208 related articles for article (PubMed ID: 36543254)
1. A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.
Rahmani E; Lemelle T; Sharp H; Smarbafzadeh E; Kablinger A
J Clin Pharm Ther; 2022 Dec; 47(12):2083-2090. PubMed ID: 36543254
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews.
Rahmani E; Lemelle TM; Samarbafzadeh E; Kablinger AS
J Head Trauma Rehabil; 2021 Jul-Aug 01; 36(4):E262-E283. PubMed ID: 33656478
[TBL] [Abstract][Full Text] [Related]
3. Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations.
Luauté J; Plantier D; Wiart L; Tell L;
Ann Phys Rehabil Med; 2016 Feb; 59(1):58-67. PubMed ID: 26700025
[TBL] [Abstract][Full Text] [Related]
4. Acute Pharmacological Management of Behavioral and Emotional Dysregulation Following a Traumatic Brain Injury: A Systematic Review of the Literature.
Nash RP; Weinberg MS; Laughon SL; McCall RC; Bateman JR; Rosenstein DL
Psychosomatics; 2019; 60(2):139-152. PubMed ID: 30665668
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis.
Williamson DR; Frenette AJ; Burry L; Perreault MM; Charbonney E; Lamontagne F; Potvin MJ; Giguère JF; Mehta S; Bernard F
Syst Rev; 2016 Nov; 5(1):193. PubMed ID: 27855720
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management for agitation and aggression in people with acquired brain injury.
Fleminger S; Greenwood RJ; Oliver DL
Cochrane Database Syst Rev; 2006 Oct; (4):CD003299. PubMed ID: 17054165
[TBL] [Abstract][Full Text] [Related]
7. Treatment of agitation following traumatic brain injury: a review of the literature.
Levy M; Berson A; Cook T; Bollegala N; Seto E; Tursanski S; Kim J; Sockalingam S; Rajput A; Krishnadev N; Feng C; Bhalerao S
NeuroRehabilitation; 2005; 20(4):279-306. PubMed ID: 16403996
[TBL] [Abstract][Full Text] [Related]
8. Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial.
Phyland RK; McKay A; Olver J; Walterfang M; Hopwood M; Hicks AJ; Mortimer D; Ponsford JL
Trials; 2020 Jul; 21(1):662. PubMed ID: 32690072
[TBL] [Abstract][Full Text] [Related]
9. Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice.
Plantier D; Luauté J;
Ann Phys Rehabil Med; 2016 Feb; 59(1):42-57. PubMed ID: 26797170
[TBL] [Abstract][Full Text] [Related]
10. The Use of Atypical Antipsychotics for Managing Agitation After Traumatic Brain Injury.
McKay A; Trevena-Peters J; Ponsford J
J Head Trauma Rehabil; 2021 May-Jun 01; 36(3):149-155. PubMed ID: 32898031
[TBL] [Abstract][Full Text] [Related]
11. Safety of dexmedetomidine for the control of agitation in critically ill traumatic brain injury patients: a descriptive study.
Bilodeau V; Saavedra-Mitjans M; Frenette AJ; Burry L; Albert M; Bernard F; Williamson DR
J Clin Pharm Ther; 2021 Aug; 46(4):1020-1026. PubMed ID: 33606290
[TBL] [Abstract][Full Text] [Related]
12. Effect of Amantadine on Agitation in Critically Ill Patients With Traumatic Brain Injury.
Gramish JA; Kopp BJ; Patanwala AE
Clin Neuropharmacol; 2017; 40(5):212-216. PubMed ID: 28816834
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: a systematic review.
Williamson D; Frenette AJ; Burry LD; Perreault M; Charbonney E; Lamontagne F; Potvin MJ; Giguère JF; Mehta S; Bernard F
BMJ Open; 2019 Jul; 9(7):e029604. PubMed ID: 31289093
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological management for agitation and aggression in people with acquired brain injury.
Fleminger S; Greenwood RJ; Oliver DL
Cochrane Database Syst Rev; 2003; (1):CD003299. PubMed ID: 12535468
[TBL] [Abstract][Full Text] [Related]
15. Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation.
Fugate LP; Spacek LA; Kresty LA; Levy CE; Johnson JC; Mysiw WJ
Arch Phys Med Rehabil; 1997 Sep; 78(9):924-8. PubMed ID: 9305262
[TBL] [Abstract][Full Text] [Related]
16. The psychopharmacology of violence: making sensible decisions.
Citrome L; Volavka J
CNS Spectr; 2014 Oct; 19(5):411-8. PubMed ID: 24571828
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacologic treatment of pathologic aggression.
Fava M
Psychiatr Clin North Am; 1997 Jun; 20(2):427-51. PubMed ID: 9196923
[TBL] [Abstract][Full Text] [Related]
18. Agitation in schizophrenia: origins and evidence-based treatment.
Citrome L
Curr Opin Psychiatry; 2021 May; 34(3):216-221. PubMed ID: 33395103
[TBL] [Abstract][Full Text] [Related]
19. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
[TBL] [Abstract][Full Text] [Related]
20. Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article.
Scott LK; Green R; McCarthy PJ; Conrad SA
J Neurosurg Pediatr; 2009 Jun; 3(6):484-7. PubMed ID: 19485732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
